Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years2006 · 79 citations
2. 2Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long‐term follow‐up results2008 · 78 citations
3. 3CD4 memory T cells survive and proliferate but fail to differentiate in the absence of CD402006 · 44 citations
4. 4Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura2001 · 552 citations
5. 5Does rituximab aggravate pre-existing hypogammaglobulinaemia?: Table 12010 · 57 citations